Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/18/2003 | WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance |
12/18/2003 | WO2003103480A2 Gene cluster analysis for coronary artery disease |
12/18/2003 | WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
12/18/2003 | WO2003078445A3 A building block forming a c=c double bond upon reaction |
12/18/2003 | WO2003078050A3 A building block forming a c-c bond upon reaction |
12/18/2003 | WO2003054167A3 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof |
12/18/2003 | WO2003040726A3 Screening for hepatitis c virus entry inhibitors |
12/18/2003 | WO2003040687A3 Isolation and purification of nucleic acids |
12/18/2003 | WO2003031608A3 Mutated abl kinase domains |
12/18/2003 | WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia |
12/18/2003 | WO2003004510A1 Two-stage protective groups for the synthesis of biopolymers |
12/18/2003 | WO2003000903A3 Regulation of human nek-like serine/threonine protein kinase |
12/18/2003 | US20030232979 Nucleic acid labeling compounds |
12/18/2003 | US20030232978 Reagents that facilitate the purification of compounds synthesized on a solid support |
12/18/2003 | US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer |
12/18/2003 | US20030232434 Antisense modulation of PTPN12 expression |
12/18/2003 | US20030232361 Preparing the arrays wherein impurities that can affect the variability and performance of the arrays are excluded from reagent solutions |
12/18/2003 | US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning |
12/18/2003 | US20030232355 A compound containing a first and a second polymeric strands, and each strand includes a sequence of ligands covalently bound by linkeres, atleast one linker selected from an amide, thioamide, sulfinamide or sufonamide |
12/18/2003 | US20030232351 Methods for analyzing methylated CpG islands and GC rich regions |
12/18/2003 | US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
12/18/2003 | US20030232339 Human TRPCC cation channel and uses |
12/18/2003 | US20030232334 Novel compositions and methods for cancer |
12/18/2003 | US20030232054 Novel nucleic acids and polypeptides |
12/18/2003 | CA2493890A1 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
12/18/2003 | CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance |
12/18/2003 | CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
12/18/2003 | CA2485874A1 T cell receptor cdr3 sequences and methods for detection |
12/17/2003 | EP1371728A1 Gene encoding adseverin |
12/17/2003 | EP1370696A2 Expression profiles and methods of use |
12/17/2003 | EP1370651A1 70 human secreted proteins |
12/17/2003 | EP1102781B1 New cofactors for methyltransferases |
12/17/2003 | CN1461806A Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application |
12/17/2003 | CN1131234C Antisense nuleic acid against protein kinase gene and its tumor-inhibiting function |
12/16/2003 | US6664388 Reagents for oligonucleotide cleavage and deprotection |
12/16/2003 | US6664376 Chimeric polypeptide molecules |
12/16/2003 | US6664112 Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides |
12/16/2003 | US6664087 Isolated human kinase proteins |
12/16/2003 | US6664079 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences |
12/16/2003 | US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels |
12/16/2003 | US6664051 Fixation of nucleotide derivatives to solid carrier |
12/16/2003 | US6664045 PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms |
12/16/2003 | US6664041 Method for preparing a viral extract containing HIV-II RNA |
12/16/2003 | CA2202167C Molecular tagging system |
12/16/2003 | CA2092038C Process for the preparation of nucleosides |
12/11/2003 | WO2003102245A1 Antisense modulation of beta-site app-cleaving enzyme 2 expression |
12/11/2003 | WO2003102214A2 Method for efficient rna interference in mammalian cells |
12/11/2003 | WO2003102185A2 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
12/11/2003 | WO2003102159A2 Novel proteins and nucleic acids encoding same |
12/11/2003 | WO2003102146A2 Aptamer constructs |
12/11/2003 | WO2003102143A2 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
12/11/2003 | WO2003102131A2 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
12/11/2003 | WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
12/11/2003 | WO2003102011A1 Method for determining oligonucleotide concentration |
12/11/2003 | WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
12/11/2003 | WO2003101283A2 Diagnostics markers for lung cancer |
12/11/2003 | WO2003070882A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
12/11/2003 | WO2003052076A3 Identification of essential genes of cryptococcus neoformans and methods of use |
12/11/2003 | WO2003048304A3 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF |
12/11/2003 | WO2003040400A3 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
12/11/2003 | WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods |
12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
12/11/2003 | WO2003020984A3 Terminal-phosphate-labeled nucleotides and methods of use |
12/11/2003 | WO2003014143A3 Haplotype map of the human genome and uses therefor |
12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
12/11/2003 | US20030229221 Process for the preparation of phosphorothioate oligonucleotides |
12/11/2003 | US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same |
12/11/2003 | US20030229219 Preparation of phosphorothioate oligomers |
12/11/2003 | US20030229218 Synthons for oligonucleotide synthesis |
12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
12/11/2003 | US20030229040 Anticancer agents; complexing with lipids |
12/11/2003 | US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening |
12/11/2003 | US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228604 System for tracing animal products |
12/11/2003 | US20030228603 Diagnostic probes for detecting caffeine and/or aspartame in beverages |
12/11/2003 | US20030228602 Using microarrays to prepare preferential nucleotide sequences for use as tools in genome analysis |
12/11/2003 | US20030228574 Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations |
12/11/2003 | US20030228568 Inducible phosphofructokinase and the warburg effect |
12/11/2003 | CA2488539A1 Novel proteins and nucleic acids encoding same |
12/11/2003 | CA2487427A1 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
12/11/2003 | CA2487024A1 Control sequences of the human corin gene |
12/11/2003 | CA2486658A1 Method for efficient rna interference in mammalian cells |
12/11/2003 | CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
12/10/2003 | EP1369495A1 Probes for detecting and identifying helicobacter pylori |
12/10/2003 | EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy |
12/10/2003 | EP1368500A2 Method for preparative production of long nucleic acids by pcr |
12/10/2003 | EP1368496A1 Method for alteration detection |
12/10/2003 | EP1368460A2 Real-time sequence determination |
12/10/2003 | EP1368368A2 Compositions and methods for binding agglomeration proteins |
12/10/2003 | EP1368051A2 Urocortin-iii and uses thereof |
12/10/2003 | EP1068216B1 Libraries of oligomers labelled with different tags |
12/10/2003 | EP0680316B1 Novel parasitic helminth proteins |
12/10/2003 | EP0674714B1 Recombinant canine gastric lipase and pharmaceutical compositions |